X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with UNITED BREWERIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs UNITED BREWERIES - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

UNITED BREWERIES 
   Change

United Breweries manufactures beer, stout, brewer's yeast, etc. It also trades in various products such as beer, batteries, processed fruits, vegetable products & liquors, marine products and chemicals. In the alcoholic beverages segment, it commands... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER UNITED BREWERIES GSK CONSUMER/
UNITED BREWERIES
 
P/E (TTM) x 34.4 92.3 37.3% View Chart
P/BV x 9.2 10.0 92.1% View Chart
Dividend Yield % 1.3 0.1 906.4%  

Financials

 GSK CONSUMER   UNITED BREWERIES
EQUITY SHARE DATA
    GSK CONSUMER
Mar-16
UNITED BREWERIES
Mar-16
GSK CONSUMER/
UNITED BREWERIES
5-Yr Chart
Click to enlarge
High Rs6,7711,225 552.7%   
Low Rs5,448756 720.6%   
Sales per share (Unadj.) Rs1,024.4192.0 533.6%  
Earnings per share (Unadj.) Rs163.311.2 1,463.4%  
Cash flow per share (Unadj.) Rs177.020.4 868.6%  
Dividends per share (Unadj.) Rs70.001.15 6,087.0%  
Dividend yield (eoy) %1.10.1 986.9%  
Book value per share (Unadj.) Rs581.579.8 729.0%  
Shares outstanding (eoy) m42.06264.41 15.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.05.2 115.6%   
Avg P/E ratio x37.488.8 42.1%  
P/CF ratio (eoy) x34.548.6 71.0%  
Price / Book Value ratio x10.512.4 84.6%  
Dividend payout %42.910.3 415.9%   
Avg Mkt Cap Rs m256,959261,898 98.1%   
No. of employees `0003.72.8 133.6%   
Total wages/salary Rs m5,0943,404 149.7%   
Avg. sales/employee Rs Th11,548.518,173.3 63.5%   
Avg. wages/employee Rs Th1,365.31,218.6 112.0%   
Avg. net profit/employee Rs Th1,841.11,056.5 174.3%   
INCOME DATA
Net Sales Rs m43,08750,758 84.9%  
Other income Rs m2,788451 617.8%   
Total revenues Rs m45,87551,209 89.6%   
Gross profit Rs m8,3497,241 115.3%  
Depreciation Rs m5742,436 23.6%   
Interest Rs m8759 1.0%   
Profit before tax Rs m10,5544,497 234.7%   
Minority Interest Rs m0-4 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,6851,542 238.9%   
Profit after tax Rs m6,8692,951 232.8%  
Gross profit margin %19.414.3 135.8%  
Effective tax rate %34.934.3 101.8%   
Net profit margin %15.95.8 274.2%  
BALANCE SHEET DATA
Current assets Rs m37,56020,144 186.5%   
Current liabilities Rs m18,15317,535 103.5%   
Net working cap to sales %45.05.1 876.4%  
Current ratio x2.11.1 180.1%  
Inventory Days Days3944 89.8%  
Debtors Days Days3082 36.5%  
Net fixed assets Rs m5,37418,588 28.9%   
Share capital Rs m421264 159.1%   
"Free" reserves Rs m24,00318,356 130.8%   
Net worth Rs m24,45621,089 116.0%   
Long term debt Rs m01,982 0.0%   
Total assets Rs m44,98841,341 108.8%  
Interest coverage x1,336.96.9 19,309.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.01.2 78.0%   
Return on assets %15.39.0 170.3%  
Return on equity %28.114.0 200.7%  
Return on capital %43.222.8 189.7%  
Exports to sales %5.10-   
Imports to sales %0.42.3 17.3%   
Exports (fob) Rs m2,211NA-   
Imports (cif) Rs m1681,143 14.7%   
Fx inflow Rs m2,81644 6,429.0%   
Fx outflow Rs m2611,882 13.8%   
Net fx Rs m2,555-1,838 -139.0%   
CASH FLOW
From Operations Rs m5,7244,939 115.9%  
From Investments Rs m-1,569-2,452 64.0%  
From Financial Activity Rs m-2,792-2,516 111.0%  
Net Cashflow Rs m1,363-29 -4,667.5%  

Share Holding

Indian Promoters % 0.0 26.9 -  
Foreign collaborators % 72.5 25.4 285.4%  
Indian inst/Mut Fund % 0.8 3.5 22.9%  
FIIs % 12.0 2.4 500.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 41.8 35.4%  
Shareholders   26,457 56,460 46.9%  
Pledged promoter(s) holding % 0.0 25.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   TILAKNAGAR IND.  GOODRICKE  KAVERI SEED  TATA COFFEE  GODFREY PHILLIPS  

Compare GSK CONSUMER With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

Apex frozen food Ltd. (IPO)

Aug 21, 2017

Should you subscribe to the IPO of Apex Frozen Foods Ltd?

ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

Feb 8, 2017

ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

Dec 7, 2016

ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Aug 21, 2017 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS